Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma ; volume:3 ; number:1 ; day:21 ; month:1 ; year:2015 ; pages:1-12 ; date:12.2015
Acta Neuropathologica Communications ; 3, Heft 1 (21.1.2015), 1-12, 12.2015
- Urheber
-
Pellegatta, Serena
Valletta, Lorella
Corbetta, Cristina
Patanè, Monica
Zucca, Ileana
Riccardi Sirtori, Federico
Bruzzone, Maria Grazia
Fogliatto, Gianpaolo
Isacchi, Antonella
Pollo, Bianca
Finocchiaro, Gaetano
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-014-0180-0
- URN
-
urn:nbn:de:101:1-2021080819222620898043
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pellegatta, Serena
- Valletta, Lorella
- Corbetta, Cristina
- Patanè, Monica
- Zucca, Ileana
- Riccardi Sirtori, Federico
- Bruzzone, Maria Grazia
- Fogliatto, Gianpaolo
- Isacchi, Antonella
- Pollo, Bianca
- Finocchiaro, Gaetano
- SpringerLink (Online service)
Ähnliche Objekte (12)
IDH1 mutation analysis – an example of putative glioma marker
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
IDH1 mutation in brain stem glioma: Case report and review of literature
ImmunoPET imaging of TIGIT in the glioma microenvironment
Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples
IDH1 mutation analysis – an example of putative glioma marker
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
IDH1 mutation in brain stem glioma: Case report and review of literature
ImmunoPET imaging of TIGIT in the glioma microenvironment
Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples
IDH1 mutation analysis – an example of putative glioma marker
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
IDH1 mutation in brain stem glioma: Case report and review of literature
ImmunoPET imaging of TIGIT in the glioma microenvironment